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METHODS

Chemicals and
Ontario (NSO) and CF clinics were linked directly to the research ID, maintaining confidentiality of personal health information. Sweat collection was performed using a Webster Model 3700
Macroduct Sweat Capillary Collection System (Wescor Inc., Logan, UT, USA). Electrodes and agar gel discs containing 0.5% w/w pilocarpine nitrate were placed in the infant's forearm for sweat stimulation after carefully cleaning the region with ethanol and distilled water. A low current (1.5 mA) was applied for 5 minutes to deliver pilocarpine to the sweat gland via iontophoresis. Sweat was then collected for 25 minutes using a coiled microbore tube containing a blue dye to facilitate visualization of the sample volume. Samples were transferred to a 0.5 mL centrifuge tube and stored in a fridge (+4°C) after taking an aliquot for chloride analysis by chloridometer (Wescor Sweat-Check Model 3120). Residual sweat samples were subsequently stored at -80°C prior to thawing when performing metabolomic studies. Overall, sixty-eight sweat specimens from screen-positive infants (≤ 3 months old) using a two-tiered algorithm based on elevated IRT/genetic mutation panel at NSO were analyzed in this study, including 50 CF unaffected infants (31 from McMaster, 19 from Sick Kids) and 18 CF affected (13 from McMaster, 5 from Sick Kids).
Instrumentation and Sweat Analysis by MSI-CE-MS.
Nontargeted metabolite profiling was performed using an Agilent 7100 capillary electrophoresis (CE) instrument and an Agilent 6550 quadrupole time-of-flight (QTOF) mass spectrometer equipped with a dual jet stream electrospray ion source (dual AJS ESI) with ion funnel technology (Agilent Technologies, Mississauga, ON, USA). Sweat samples were analyzed by MSI-CE-MS in positive (ESI+) and negative (ESI-) ion modes to cover cationic and anionic metabolites after thawing specimens slowly to room temperature on ice. System control and data acquisition were performed using the Mass Hunter Workstation Software (Data Acquisition, version B.07.01, Agilent
Technologies, 2014). The CE separation was carried out using uncoated fused-silica capillaries (Polymicro Technologies, Phoenix, AZ, USA) with 50 µm inner diameter and 120 cm total length. The background electrolyte (BGE) used for cationic metabolites was composed of 1 M formic acid and 15% v/v acetonitrile, pH 1.8 [1] , whereas the BGE for anionic species consisted of 50 mmol/L ammonium bicarbonate, pH 8.5 (adjusted with 10% v/v ammonium hydroxide) [2] . New capillaries were conditioned by flushing with methanol, water, 1 M sodium hydroxide, water, and formic acid as BGE (15 minutes each). For ESI-, this conditioning was followed by 15 minutes flush with water and 30 minutes flush with ammonium bicarbonate as BGE. The capillary was flushed with BGE for 15 minutes before each separation, followed by the MSI injection sequence in which seven samples were injected hydrodynamically (5 seconds, 50 mbar) and interspaced with BGE (40 seconds, 50 mbar), ending with BGE (5 seconds, 50 mbar).
Separations were performed using normal polarity with an applied voltage of 30 kV and capillary maintained at 25°C. Pressure-assisted separation was used to speed up the analysis of anionic metabolites under high pH and normal polarity by applying a pressure gradient of 1 mbar/min from 10 to 20 minutes and 3 mbar/min from 20 to 38 minutes. A standard mixture, and a QC run with blank (i.e., internal standard solution in water) were analyzed at the beginning of each day to equilibrate the CE-MS system and ensure high data quality (i.e., sample carry-over effects, good reproducibility, ion spray and current stability etc.) prior to the randomized analysis of pairs of sweat samples with QC (i.e., the same pooled sweat was used consistently throughout study with a frozen aliquot thawed each day) when using MSI-CE-MS. For overnight storage, capillaries were flushed with water for 10 minutes and air dried for 10 minutes. As preventative maintenance, the CE electrode was cleaned daily with 50% v/v isopropanol-water and methanol.
The Q-TOF system was calibrated every morning before analysis using an Agilent tune mixture over a m/z 50-1700 range. An Agilent 1260 Infinity series isocratic pump equipped a 100:1 splitter was used to deliver sheath liquid to the CE-MS interface at a flow rate of 10 µL/min. The sheath liquid for ESI+ consisted of 60% v/v methanol in water with 0.1% v/v formic acid, whereas for ESI-it was 50% v/v methanol in water. Purine and HP-0921 (API-TOF Reference Mass Solution Kit, Agilent Technologies) were added to the sheath liquid as reference masses for real-time automatic mass calibration. The nebulizer gas kept at 8 psi, while the flow rate for the drying gas was maintained at 16 L/min (300°C), and the sheath gas flow was kept at 3. for ESI+ experiments to prevent saturation of highly abundant cationic metabolites, whereas ESI-experiments were performed in high resolution (HiRes 4 GHz) to improve detection of anionic metabolites that in general have lower sensitivity. As preventative maintenance, the ion source was wiped daily with lint-free cloth and 50% v/v isopropanol-water.
All samples were prepared by a simple dilution step (typically 4-fold in in ultra-grade LC-MS water) using a volume of 5 µL (unless otherwise stated) of residual infant sweat specimen from screen-positive CF infants containing 10 µM of the internal standards, 3-chloro-L-tyrosine (ClTyr) and sodium 2-naphthalenesulfonate (NMS), followed by mixing using a vortex for 30 seconds. A pooled quality control (QC) sample (n=10) was prepared by combining equal aliquots of sweat samples collected from 10 children, including five confirmed CF cases and five CF unaffected individuals. Those samples were not individually analyzed in this study for exceeding the age criteria (≤ 3 months old) or for lacking clinical information from NBS (e.g., siblings of recently diagnosed CF infant, CF affected children who were born before implementation of NBS for CF). In this case, the QC was not prepared from the actual study samples due to limited volumes remaining in some infant's sweat specimens after chloridometer analysis.
Metabolomic studies were initially performed using a dilution trend filter in MSI-CE-MS [1, 3] with a QC sample for rigorous peak selection/data filtering of cationic and anionic metabolites Table S1 based on confidence levels for metabolite identification (i.e., level 1 indicative of confirmation of unknown ion with authentic standard) based on co-migration and MS/MS match of product ion spectra at different collisional energies as recommended by the Metabolomics Standards Initiative [4] . MFE was also performed in sweat samples from four authentic CF and two unaffected CF infants in order to identify unique molecular features (m/z:RMT) that were not detected in the original pooled QC.
Individual sweat samples were analyzed in duplicate using temporal signal pattern recognition in MSI-CE-MS for confident assignment of peaks that also confirms their sample of origin even when a compound is not detected in one or more samples in the serial injection sequence [5] . As shown in Figure 1 , three sweat samples were prepared in duplicate using different dilution factors, which results in a pattern of ion signals as a function of time that allows for simple visual peak assignment. Furthermore, this configuration allows the introduction of a pooled QC within each run, which is critical for evaluating long-term system variability/technical variation during data acquisition. Sweat samples were analyzed in randomly assigned order and injection positions by MSI-CE-MS with a QC randomly inserted in positions 1, 3, 5 or 7. Sample dilution was optimized for each ionization mode in order to prevent saturation and signal suppression due to certain high abundant sweat components. In this case, sweat samples were 10-and 20-fold diluted for cation analysis and 4 and 8-fold diluted for anion analysis. Sweat samples were analyzed in two separate batches of runs performed about 10 months apart due to delays for acquisition of sweat specimens from an adequate number of screen-positive CF infants given the incidence rate of CF in the population (1:3600) as compared to total carriers (1:30), however only 39 CFTR mutations/3 variants are included within screening panel for CF in Ontario [6] .
Data Processing and Statistical Analysis. Raw data was extracted using Mass Hunter
Workstation Software (Qualitative Analysis, version B.06.00, Agilent Technologies, 2012).
Untargeted analysis was performed using MFE and Molecular Formula Generator tools followed by a personal compound database search. Features were extracted in centroid using 10 ppm mass window and labeled according to their m/z, RMT and ionization mode (p = ESI+, n = ESI-).
Peaks were integrated after smoothing (quadratic/cubic Savitzky-Golay, 15 points) and peak areas and migration times were transferred to Excel (Microsoft Office) for calculation of relative integrated peak area (RPA), relative migration time (RMT), relative standard deviation (RSD) and average fold-changes (FC), as well as conversion into a data matrix format. Only molecular features detected in at least 75% of the samples were included in the data matrix for subsequent data transformation and statistical analysis. Due to between-subject variations in sweat rate/volume among infants, a probabilistic quotient normalization (PQN) method was evaluated for normalizing sweat metabolomic data to correct for dilution/hydration status [7] . Briefly, the most probable dilution factor determined by PQN was derived from the ratio of the median response for ions measured in a sample relative to pooled sweat sample (QC) used as a reference.
Additionally, batch effect correction was performed via an empirical Bayes method (ComBat) on MetaboAnalyst 3.0 [8] . Other batch correction algorithms were also evaluated based on QCs or study samples [9] . Although the top-ranked metabolites remained consistent when using different batch adjustment methods, ComBat was adopted for providing better overlap between batches, as indicated by a principal component analysis (PCA) 2D scores plots (data not presented).
Supervised multivariate data analysis was also performed on MetaboAnalyst 3.0 using partial least-squares-discriminate analysis (PLS-DA) in order to identify top-ranked sweat metabolites associated with CF disease status in affected infants based on variable importance in projection (VIP) scores on PC1. The PLS-DA model was validated using leave-out-one-at-at-time crossvalidation in conjunction with permutation testing. Normality tests, Spearman rank correlation and nonparametric statistical analysis (Mann-Whitney U test) were performed using the Statistical Package for the Social Science (SPSS, version 18), and MedCalc (MedCalc Inc.) was used for ROC curves and boxplots.
Structural Elucidation of Unknown Sweat Metabolites by CE-MS/MS. MS/MS experiments
were performed using a single long injection in CE-MS/MS to enhance signal response when Table S1 .
Pilocarpine Gel Extracts and Blanks for Sweat Collection Device. A small piece of one new and two used gel discs (≈ 0.2 g) was transferred to a 1.5 mL centrifuge tube, sonicated for 10 min with 1 mL of water and centrifuged for 10 min at 14,000 g to separate gel debris. Two aliquots of the supernatant were collected and diluted 20 and 40-fold in water containing the internal standards Cl-Tyr and NMS before analysis by MSI-CE-MS. A standard solution of pilocarpine was also extracted as a control, indicating a satisfactory mean recovery of 90% for pilocarpine. A blank for the sweat collection device was prepared to evaluate the presence background components in sweat specimens collected using this system. First, a 55 µL aliquot of water was inserted in the central opening of the coiled microbore tube and collected in the opposite side of the tube in order to capture compounds potentially originated from the plastic material. Then, another 55 µL aliquot of water was placed in the back of the collection device, over the blue dye spot located next to the tube opening. In this case, the objective was to evaluate if any compounds identified in sweat samples were coming from the blue dye. The blanks for the collection tube and blue dye were diluted 4, 8, and 16-fold in water containing Cl-Tyr and NMS and analyzed by MSI-CE-MS in ESI+ and ESI-, respectively. . Overview of batch effects and application of a batch-correction algorithm on representative metabolites in original data as summarized in a 2D scores plot using PCA. QC plots for some example compounds comparing changes in RPAs (A) and batch-corrected RPAs (B). The step-change in RPAs observed for glutamine was corrected by batch effect adjustment. On the other hand, the correction algorithm had a negative impact on some compounds not initially affected by batch effect (e.g., asparagine and pilocarpic acid). PCA plots show overall variability in the responses for anions (C) and cations (D) before and after batch effect adjustment, respectively. Figure S4 . Boxplots comparing age, birth weight, sweat chloride and dried blood spot IRT levels in CF and non-CF screen-positive CF infants. Infants in the two groups had no significant difference with respect to testing age (A) and birth weight (B), whereas sweat chloride (C) and IRT (D) were significantly elevated in screen-positive affected CF cases. Figure S5 . Percentage of pilocarpine and pilocarpic acid in gel disc water extracts. Samples of new and used gel discs used in pilocarpine-stimulated iontophoresis for sweat collection were extracted in water and compared to a control (i.e., pilocarpine solution in water). A low background fraction of pilocarpic acid (0.1-1.2%) was detected in the extracts, which provides evidence that the much higher pilocarpic acid concentrations measured in sweat were generated in vivo from screen-positive infants. . Pooled infant sweat samples were analyzed as a QC run (A), and a dilution trend filter (B) for feature selection was used in MSI-CE-MS under alkaline conditions and negative ion mode detection. In both cases, MEHP is reproducibly detected in infant sweat samples with good precision having a distinct linear dilution trend (C) that does not originate from the background during spray formation.
